What to know about GLP-1 use and adolescents
Dr. Rachel Pessah Pollack, an endocrinologist at NYU Langone Health, joins "CBS Mornings" to talk about a new study that showed promising results for GLP-1 use in adolescents.
Watch CBS News
Dr. Rachel Pessah Pollack, an endocrinologist at NYU Langone Health, joins "CBS Mornings" to talk about a new study that showed promising results for GLP-1 use in adolescents.
Retatrutide, an experimental weight loss drug still undergoing clinical trials at Eli Lilly, is being marketed online and illegally sold to U.S. clients, a CBS News investigation found. CBS News investigative reporter and producer Daniel Gilbert has the story.
In 1970, about 1 in 20 children were affected by obesity; today, it's 1 in 5. Dr. Jonathan LaPook looks at programs aimed at helping kids (and their families) get healthy the old-fashioned way, by eating right and exercising.
In 1970, about 1 in 20 children were affected by obesity; today, it's 1 in 5, with diet and exercise both key factors in the increase. CBS News chief medical correspondent Dr. Jonathan LaPook looks at programs aimed at helping kids get healthy the old-fashioned way, by eating right and exercising, while helping decrease the risk of problems tied to obesity later in life, such as diabetes, heart disease, and even cancer.
In the U.S. the percentage of obese adults is about ten times what it is in Japan. What differentiates the Japanese diet, and how are schools making it their mission to give Japanese children a taste of a healthy life?
Starting in 2027, the Danish pharma firm will sell its weight-loss and diabetes drugs for $675 per month.
Whole milk is heading back to school lunch cafeterias.
A new report found that the number of people surviving cancer is at a historic high. The new findings published by the American Cancer Society found that the five-year-survival rate for all cancers has reached 70% for the first time. That's up from just half in the mid 1970s. CBS News chief medical correspondent Dr. Jon LaPook breaks it down.
The World Health Organization issued new guidelines recommending the use of GLP-1 drugs for adults with obesity and called for action on manufacturing and affordability.
The U.K. this week extended its sugar tax to some coffee drinks and milkshakes in an ongoing effort to fight obesity.
In British supermarkets, the war against sugar continues in the name of children's health. Holly Williams has the details.
President Trump on Thursday unveiled agreements slashing the prices of two pharmaceutical companies' weight loss drugs. Novo Nordisk CEO Mike Doustdar joins "The Takeout" to unpack the cost-cutting effort.
As more Americans turn to weight loss drugs, the U.S. adult obesity rate is declining, according to new survey data from Gallup.
In January, a group of health professionals advocated for an update to the definition of obese. They recommended including factors like waist-to-hip ratio in addition to body mass index, or BMI. Now, a new study found that under that definition, nearly 70% of U.S. adults would be considered obese. Dr. Lindsay Fourman, one of the study's authors, joins "The Daily Report" to discuss.
A new drug is helping families who've spent years padlocking fridges, chaining garbage cans, and hiding food as their children with Prader-Willi syndrome deal with unrelenting hunger.
There may soon be a new medication option for losing weight. Eli Lilly's experimental pill appears to work as well as the injected drug Ozempic to lower the weight of diabetes patients. Dr. Jon LaPook has more.
The Biden administration had proposed to expand coverage of the drugs.
A school in Minnesota is encouraging its students to ditch their phones during "phone-free February." CBS News Minnesota's Kirsten Mitchell has the details and reaction.
While a new report from the American Cancer Society showed an overall drop in U.S. cancer deaths, it also highlighted an uptick in the number of young women being diagnosed with the disease. Dr. Larry Norton, breast medical oncologist at the Memorial Sloan Kettering Cancer Center, joins "The Daily Report" to discuss.
Body Mass Index, or BMI, has long been criticized as an unreliable method for measuring obesity — and now a group of experts is sharing new recommendations for how to use it.
A group of experts says Body Mass Index, or BMI, used by doctors to measure obesity, is not a good method. CBS News medical contributor Dr. Celine Gounder explains the new recommendations.
2024 was a year of historic health headlines. From Ozempic to E. coli, CBS News medical contributor Dr. Céline Gounder joins to look back at the medical stories that defined the year.
Independent Sen. Bernie Sanders of Vermont spoke to CBS News on Thursday about Robert F. Kennedy Jr., President-elect Donald Trump's pick to run the Department of Health and Human Services. Sanders said he agreed with Kennedy's recent comments about the food industry and criticized some of his views as "very wrong." CBS News correspondent Natalie Brand has more.
A New White House proposal would make Medicare and Medicaid cover GLP-1 weight loss drugs for people who are obese. The move would expand affordable access to the drugs to some 7.4 million people. Dr. Jon LaPook has more.
The Biden administration is proposing a new rule that would make popular weight loss drugs like Ozempic covered by Medicare and Medicaid. CBS News medical contributor Dr. Celine Gounder discusses whether the current or next administration can make this happen.